OREX

Will Arena Seize An Opportunity?

moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboardSee who Orexigen is hiring next, click here to view […]

Orexigen Therapeutics’ CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Mike Narachi Thank you, Heather. Late last year, we announced successful results of the Light Study interim analysis. We believe these results clearly address the single approval deficiency the FDA identified … moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboardSee who Orexigen is hiring next, click here […]

Orexigen Therapeutics to Host Full Year and Fourth Quarter 2013 Financial Results Conference Call and Webcast

[at noodls] – SAN DIEGO, March 3, 2014/PRNewswire/ — Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, will announce financial results for the full year and … moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboardSee who Orexigen is hiring next, click here to view […]

Orexigen Therapeutics to Present at the 34th Annual Cowen and Co. Health Care Conference

[PR Newswire] – SAN DIEGO, Feb. 27, 2014 /PRNewswire/ — Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the 34 th Annual Cowen and Co. Health Care Conference … moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboardSee who Orexigen is hiring next, click here […]

8:04 am Orexigen Therapeutics receives the Day 120 List of Questions regarding its NB32 MAA from the EMA Committee; co is confident that it can successfully address all of the questions posed

moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboardSee who Orexigen is hiring next, click here to view […]

Orexigen Provides Update on Its NB32 European Marketing Authorization Application

[PR Newswire] – SAN DIEGO, Feb. 25, 2014 /PRNewswire/ — Orexigen® Therapeutics, Inc. (OREX) today announced that the Company received the Day 120 List of Questions (LoQs) regarding its NB32 Marketing Authorization Application (MAA) from the European Me moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboardSee who Orexigen is hiring next, […]

GC Aesthetics raises $60M to Fund Global Growth and New Product Development

[PR Newswire] – GC Aesthetics (http://www.gcaesthetics.com), one of the largest independent aesthetic companies globally, has raised $40M of financing from new investor OrbiMed, alongside nearly $20M from existing investors including Montreux Equity Part moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboardSee who Orexigen is hiring next, click here to view […]

10 States Where Cancer Incidence Is the Highest

moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboardSee who Orexigen is hiring next, click here to view […]